These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5994042)

  • 1. [Strains of foot-and-mouth viruses which can be used for live vaccines].
    Onoufriev V
    Bull Off Int Epizoot; 1966; 65(11):1967-73. PubMed ID: 5994042
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apropos of the conclusions (Point I, Section E) of the 11th conference of the Permanent Commission on Foot-and-Mouth Disease of the International Office of Epizootic Diseases in Paris].
    Röhrer H
    Bull Off Int Epizoot; 1966; 65(11):1921-8. PubMed ID: 5994040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Report on the characteristics of foot-and-mouth disease virus capable of being used as live vaccines].
    Asso J; Paraf A; Aynaud JM; Lucas A; Dhennin L; Gayot G
    Bull Off Int Epizoot; 1966; 65(11):1929-36. PubMed ID: 4296532
    [No Abstract]   [Full Text] [Related]  

  • 4. Standards for modified strain vaccines in foot-and-mouth disease.
    Brooksby JB
    Bull Off Int Epizoot; 1966; 65(11):1941-7. PubMed ID: 5994041
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy testing of anti-foot-and-mouth disease vaccines in guinea pigs using myotropic strains].
    Eissner G; Böhm HO
    Dev Biol Stand; 1976; 35():279-83. PubMed ID: 198295
    [No Abstract]   [Full Text] [Related]  

  • 6. [The efficacy of foot and mouth disease vaccines after long- term storage].
    Wittmann G
    Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
    [No Abstract]   [Full Text] [Related]  

  • 7. [Examination of foot-and-mouth disease virus strains with regard to their suitability for modified virus vaccine preparation].
    Wittmann G; Ahl R; Bauer K
    Bull Off Int Epizoot; 1966; 65(11):1901-20. PubMed ID: 4297170
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant DNA technology for the preparation of subunit vaccines.
    Bachrach HL
    J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative testing of methods for the control of foot-and-mouth disease vaccines on guinea pigs].
    Tekerlekov P; Mitev G; Nikolova E; Gergov P
    Vet Med Nauki; 1975; 12(1):25-9. PubMed ID: 1209994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative immunologic study on cattle of 2 strains of foot-and-mouth disease type O virus: O Flanders and O Spain 64].
    Fontaine J; Gayot G; Dubouclard C; Dhennin L; Roumiantzeff M; Terre J; Dhennin L
    Bull Off Int Epizoot; 1966; 65(11):2051-62. PubMed ID: 5994044
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
    Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
    J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interference of viruses with foot-and-mouth disease].
    Gizatullin KhG; Gumerov NK
    Veterinariia; 1969 Sep; 9():23-4. PubMed ID: 5392424
    [No Abstract]   [Full Text] [Related]  

  • 13. [Durability testing of a DEAE dextran-containing foot-and-mouth-disease vaccine in pigs].
    Rödder H
    Dtsch Tierarztl Wochenschr; 1975 May; 82(5):183-4. PubMed ID: 770110
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination against foot-and-mouth disease.
    Morgan DO; Moore DM; McKercher PD
    Prog Clin Biol Res; 1980; 47():169-78. PubMed ID: 6259663
    [No Abstract]   [Full Text] [Related]  

  • 15. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the immunologic properties of foot-and-mouth disease vaccines].
    Tekerlekov P; Gergov P; Nikolova E
    Vet Med Nauki; 1982; 19(3):29-34. PubMed ID: 6291225
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunogenic properties of inactivated cultured foot-and-mouth disease vaccine].
    Siusiukin AA; Kravets IK; Siusiukina MS; Efimov NI; Sergeev VA; Mel'nik RI
    Veterinariia; 1967 Apr; 44(4):17-8. PubMed ID: 5615318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunogenic properties of an experimental vaccine against foot-and-mouth disease].
    Siusiukin AA; Kravets IK; Tsvetkova NE; Pavlov VG
    Veterinariia; 1971 May; 5():40-2. PubMed ID: 5158658
    [No Abstract]   [Full Text] [Related]  

  • 19. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.